Navigation Links


Tag: "altering" at biology news

Columbia research lifts major hurdle to gene therapy for cancer

...and glioma (brain) tumors.Dr. Fisher's team is now altering the virus and developing additionalviruses based on the PEG switch for use in clinical trials withpatients. Other investigators associated with the PNAS study includeDrs. Zao-zhong Su (research scientist), Devanand Sarkar (associateresearch scientist...

FDA Approves Human Hookworm Vaccine for Phase I Safety Trials

...ract with other components of the NMD complex ?and altering the amount of Staufen1 in the cell didn't change N...reased the half-life of these RNAs. Significantly, altering the amount of another NMD factor didn't affect these RNAs. Thus, Staufen1 and Upf1, together, degra...

A new mechanism of regulating RNA degradation

...ract with other components of the NMD complex ?and altering the amount of Staufen1 in the cell didn't change N...reased the half-life of these RNAs. Significantly, altering the amount of another NMD factor didn't affect these RNAs. Thus, Staufen1 and Upf1, together, degra...

1 2 3 4 5

Other Tagsquestionable 2coverage 2coverage 3coverage 4coverage 5coverage 6coverage 7coverage 8coverage 9coverage 10slowly 2slowly 3slowly 4slowly 5slowly 6
(Date:10/13/2008)... moths may hitch a ride on the wind, but a new stu... a Cell Press publication, confirms that they are ...in Current Biology offered the first evidence th... compass, sailing on favorable winds to reach thei...days. Now, the research team that brought us that ...
(Date:10/13/2008)...that the embryonic mouse heart has an astounding c...erved only in non-mammalian species. The research,... of the journal Developmental Cell , describes th...ic heart to replace diseased tissue through compen...rs of the mitochondria, a cell structure required ...
(Date:10/12/2008)...d a new possible explanation for why people who ea...ainst the spread of cancers. , They have shown t...fruits and vegetables, binds to and is believed to... role in all stages of cancer progression. , "Mo...based on population studies," says Professor Vic M...
(Date:10/12/2008)...apon against HIV, but until recently no one knew h...online by the journal Nature reveals the atomic ...C-3G and suggests new directions for drug develop.... It is capable of stopping HIV at the first step ...s RNA into viral DNA. , The study,s authors, led...
Breaking Biology News(10 mins):Migratory moths may hitch their rides, but they're anything but drifters 2Embryonic heart exhibits impressive regenerative capacity 2Pectin power 2Body's anti-HIV drug explained 2Cynosure to Announce Third Quarter 2007 Financial Results on November 1 4022 1Cynosure to Announce Third Quarter 2007 Financial Results on November 1 4022 2WuXi PharmaTech 28NYSE 3A WX 29 Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia 1338 1WuXi PharmaTech 28NYSE 3A WX 29 Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia 1338 2Sigma Aldrich Introduces N TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult to Transfect Cell Types 1335 1Sigma Aldrich Introduces N TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult to Transfect Cell Types 1335 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 1Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment Naive Hepatitis C Patients Show a High Rate of Early Virologic R 561 9
(Date:10/14/2008)... Leading Supplemental Insura... Quarter to Review Employee Benefits , ... Combined Insurance , a leading provider of supple...fourth quarter as time to review employee benefits...n added incentive to help retain employees. These ...
(Date:10/14/2008)... LegalView re-launched its m...ssistance to the hundreds of thousands of victims ...d from medical malpractice. Medical malpractice ca...dure, including giving birth. , ...w.com, the number one legal resource on the Intern...
(Date:10/14/2008)... ASCOT, England, October 14 /PRNewswire/ -- Resear... Strathclyde, have started work on a 3.5 year,proj...corporating CVD,(chemical vapour deposition) diamo...ads the world in the field of CVD diamond synthesi...ond Raman laser could open up a raft of new,applic...
(Date:10/13/2008)...rincipal Shareholder Shows Continuing Commitment b...ove Speed-to-Market for Next Generation ...RMINGHAM, Ala., Oct. 13 /PRNewswire-FirstCall/ -- ...: HSSO) and Emageon Inc.,(Nasdaq: EMAG ) today an...HSS to acquire 100% of the stock of Emageon. The a...
Breaking Medicine News(10 mins):Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance 2Health News:LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 2Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 3Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 4Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 5Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 6
Other Contentspathologypathologypathologypathologypathologypathologypathologyassistantassistantassistantassistantassistantassistantlaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratorylaboratoryventilationventilationventilationventilationventilationhighhighhighhighhighhighhighhighhighhighprogramprogramprogramprogramprogramprogramprogramprogramprogramtrainingtrainingtrainingtrainingtrainingtrainingtrainingtraining